Sanofi (SNY)
43.33
+0.56
(+1.31%)
USD |
NASDAQ |
Sep 14, 16:00
43.33
0.00 (0.00%)
After-Hours: 20:00
Sanofi Market Cap : 105.21B for Sept. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 14, 2026 | 105.21B |
| September 11, 2026 | 103.85B |
| September 10, 2026 | 103.73B |
| September 09, 2026 | 104.05B |
| September 08, 2026 | 104.79B |
| September 04, 2026 | 107.42B |
| September 03, 2026 | 107.64B |
| September 02, 2026 | 107.98B |
| September 01, 2026 | 107.74B |
| August 31, 2026 | 107.71B |
| August 28, 2026 | 108.83B |
| August 27, 2026 | 108.88B |
| August 26, 2026 | 110.29B |
| August 25, 2026 | 111.75B |
| August 24, 2026 | 110.94B |
| August 21, 2026 | 111.33B |
| August 20, 2026 | 109.63B |
| August 19, 2026 | 111.28B |
| August 18, 2026 | 109.20B |
| August 17, 2026 | 107.84B |
| August 14, 2026 | 106.16B |
| August 13, 2026 | 106.31B |
| August 12, 2026 | 106.14B |
| August 11, 2026 | 105.77B |
| August 10, 2026 | 105.58B |
| Date | Value |
|---|---|
| August 07, 2026 | 105.53B |
| August 06, 2026 | 104.15B |
| August 05, 2026 | 103.88B |
| August 04, 2026 | 103.64B |
| August 03, 2026 | 104.29B |
| July 31, 2026 | 104.61B |
| July 30, 2026 | 104.15B |
| July 29, 2026 | 108.90B |
| July 28, 2026 | 110.58B |
| July 27, 2026 | 106.26B |
| July 24, 2026 | 104.69B |
| July 23, 2026 | 104.72B |
| July 22, 2026 | 105.76B |
| July 21, 2026 | 105.66B |
| July 20, 2026 | 106.22B |
| July 17, 2026 | 107.86B |
| July 16, 2026 | 106.77B |
| July 15, 2026 | 105.49B |
| July 14, 2026 | 104.28B |
| July 13, 2026 | 106.26B |
| July 10, 2026 | 105.06B |
| July 09, 2026 | 106.02B |
| July 08, 2026 | 103.32B |
| July 07, 2026 | 103.80B |
| July 06, 2026 | 102.91B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AstraZeneca PLC | 507.99B |
| GSK Plc | 101.24B |
| Eli Lilly & Co. | 1.072T |
| Merck & Co., Inc. | 357.58B |
| Novo Nordisk A/S | 145.38B |
Market Cap Related Metrics
| PE Ratio | 22.32 |
| PS Ratio | 1.958 |
| PEG Ratio | 3.170 |
| Price to Book Value | 1.460 |
| Price to Free Cash Flow | 10.59 |
| Price | 43.33 |
| Earnings Yield | 4.48% |
| PEGY Ratio | 1.767 |
| Operating PE Ratio | 7.207 |
| Normalized PE Ratio | 12.61 |